by Naman Julka-Anderson and Jo McNamara
Rad Chat is a forward-thinking global knowledge hub where healthcare professionals can advance their knowledge and expertise in radiotherapy and oncology by utilising the award winning, first therapeutic radiographer led oncology podcast and social media channels. We're empowering healthcare professionals worldwide by providing free, CPD-accredited radiotherapy and oncology education, by sharing real-world experience, expert insights, best practice and patient perspectives, we're helping healthcare professionals’ advance cancer care and improve patient outcomes.
Language
🇺🇲
Publishing Since
11/20/2019
Email Addresses
1 available
Phone Numbers
0 available
April 28, 2025
<p><strong>Trigger Warning:</strong> cancer, gynaecological cancer, death and dying, gender based violence, mental health and brachytherapy.</p><p><br></p><p><strong>Episode 165: </strong>Part of the <strong>education and workforce development</strong> (series 57).</p><p><br></p><p><strong>Description:</strong> In this powerful episode, Naman Julka-Anderson and Jo McNamara sit down with Dr. Gemma Eminowicz to hear about her work in utilising MR-Linac for gynaecological cancer. </p><p><br></p><p>Dr. Gemma Eminowicz MBChB, MRCP, FRCR, MD(Res) is a consultant clinical oncologist and brachytherapy lead treating gynaecological cancers at University College London Hospital (UCLH). She is also an honorary clinical associate professor at University College London (UCL), chair of the GEC-ESTRO gynae working group, member of ESTRO gynae focus group, organiser of gyn-SMART webinars and principle investigator on many systemic therapy clinical trials including at a UK level (eg Keynote B21). She has published 26 oncology papers, 8 as first author and multiple book chapters. She has been heavily involved in the practice changing INTERLACE trial from radiotherapy quality assurance to analysis of final results and dissemination of primary and secondary outcome data. She remains active within ESTRO, ESGO, BGCS and GTG-UK and strives to improve patient care through multidisciplinary treatments focusing on systemic therapy and high quality radiotherapy. </p><p><br></p><p><strong>CPD Reflection Points:</strong></p><ol><li>Read about the types of gynaecological cancers, along with signs and symptoms of each: <a href="https://eveappeal.org.uk/information-and-advice/gynaecological-cancers/">https://eveappeal.org.uk/information-and-advice/gynaecological-cancers/</a>.</li><li>Consider how you could support people who have to have brachytherapy treatment.</li></ol><p>Complete this form for your accredited digital badge: <a href="https://bit.ly/3GbtR1X">Digital Badge Form</a>.</p><p><br></p><p><strong>Links from the Episode:</strong></p><ul><li>Dr. Gemma Eminowicz <a href="https://www.uclh.nhs.uk/our-services/find-consultant/dr-gemma-eminowicz">https://www.uclh.nhs.uk/our-services/find-consultant/dr-gemma-eminowicz</a></li><li>GEC-ESTRO gynaecology committee: <a href="https://www.estro.org/About/ESTRO-Organisation-Structure/Committees/GEC-ESTRO-Committee">https://www.estro.org/About/ESTRO-Organisation-Structure/Committees/GEC-ESTRO-Committee</a></li><li>ESTRO Gynaecology focus group: <a href="https://www.estro.org/About/ESTRO-Organisation-Structure/Focus-Groups/Gynaecology">https://www.estro.org/About/ESTRO-Organisation-Structure/Focus-Groups/Gynaecology</a></li><li>GYN-Smart webinars: <a href="https://sites.google.com/view/gyn-smart">https://sites.google.com/view/gyn-smart</a></li><li>Keynote B21: <a href="https://www.annalsofoncology.org/article/S0923-7534(24)03822-5/fulltext">https://www.annalsofoncology.org/article/S0923-7534(24)03822-5/fulltext</a></li><li>INTERLACe trial: <a href="https://www.ctc.ucl.ac.uk/TrialDetails.aspx?Trial=89">https://www.ctc.ucl.ac.uk/TrialDetails.aspx?Trial=89</a></li><li>MR-Linac treatment Genesis Care: <a href="https://www.genesiscare.com/uk/treatment/radiotherapy/mr-linac">https://www.genesiscare.com/uk/treatment/radiotherapy/mr-linac</a></li></ul><p><strong>Research links from the Episode:</strong></p><ul><li><a href="https://www.sciencedirect.com/science/article/abs/pii/S147020452400192X">Creutzberg C, Kim JW, Eminowicz G et al. The Gynecologic Cancer InterGroup(GCIG) consensus recommendations for clinical research in Endometrial Cancer. Lancet oncology September 2024<strong>.</strong></a></li><li><a href="https://www.brachyjournal.com/article/S1538-4721(24)00044-8/abstract">Sarwar A, Eminowicz G. Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence. Brachytherapy, 2024,ISSN 1538-4721, https://doi.org/10.1016/j.brachy.2024.03.002.</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2216334">Mirza MR, RUBY investigators. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. N Engl J Med. 2023 Jun 8;388(23):2145-2158.</a></li><li><a href="https://www.clinicaloncologyonline.net/article/S0936-6555(22)00609-4/fulltext">Gaze MN, Smeulders N, Ackwerh R, Allen C, Bal N, Boutros M, Cho A, Eminowicz G, Gill E, Fittall MW, Humphries PD, Lim P, Mushtaq I, Nguyen T, Peet C, Pendse D, Polhill S, Rees H, Sands G, Shankar A, Slater O, Sullivan T, Hoskin PJA National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years. Clin Oncol(R Coll Radiol). 2022 Dec 30:S0936-6555(22)00609-4. doi: 10.1016/j.clon.2022.12.008. Online ahead of print.</a></li><li><a href="https://www.brachyjournal.com/article/S1538-4721(22)00035-6/abstract">Sarwar A, Lalli N, Eminowicz G. Ureter dose optimization during image guided brachytherapy for cervical cancer. Brachytherapy. 2022 Apr 11:S1538-4721(22)00035-6.</a></li></ul><p><strong>Rad Chat Links:</strong></p><ul><li><a href="http://www.radchat.co.uk">Rad Chat Website</a></li><li><a href="https://linktr.ee/radchat">Link Tree</a></li><li><a href="https://www.facebook.com/RadChatPodcast/">Facebook</a></li><li><a href="https://www.instagram.com/rad__chat/">Instagram</a></li><li><a href="https://uk.linkedin.com/company/radtalk">LinkedIn</a></li><li><a href="https://www.tiktok.com/@rad_chat">TikTok</a></li><li><a href="https://bsky.app/profile/radchat.bsky.social">BlueSky</a></li><li><a href="https://www.youtube.com/@radchat2259">YouTube</a></li></ul><p><strong>Credits:</strong> Music and jingle credits: <a href="https://www.linkedin.com/in/ben-imaging/">Dr. Ben Potts</a> and <a href="https://www.linkedin.com/in/adam-cooke-2b9502216/">Adam Cooke</a>.</p>
April 22, 2025
<p><strong>Trigger Warning:</strong> This episode discusses cancer.</p><p></p><p><strong>Episode 164: </strong>Part of the<strong> workforce and education</strong> series (part 56).</p><p><strong>Description:</strong> In this educational episode, Naman Julka-Anderson and Jo McNamara sit down with Dr. James Lam talking about his career as a medical oncologist and work around developing a novel machine learning algorithm to identify new cancer drug targets.</p><p></p><p>James studied Medicine at Cambridge and completed his MBBS at UCL, qualifying in 2017 with Distinction. He holds an MA(Cantab) for research in retinal neuroscience and was ranked first among all UK Medical Oncology ST3 applicants in 2021.</p><p>Awarded an NIHR Academic Clinical Fellowship, he has contributed to practice-changing oncology trials and cancer cachexia research with the TRACERx Consortium. Now at BioCorteX, he applies computational metagenomics and AI to shaping future cancer care.</p><p>James remains dedicated to oncology research, with a strong interest in nutrition, fitness, and health optimisation.</p><p></p><p><strong>CPD Reflection Points:</strong></p><ol><li>Read through the three publications attached to show notes and reflect upon how this research may impact on clinical practice. </li></ol><p>Complete this form for your accredited digital badge: <a href="https://bit.ly/3GbtR1X">Digital Badge Form</a>.</p><p></p><p><strong>Links from the Episode:</strong></p><ul><li><a href="https://biocortex.com/">https://biocortex.com/</a></li></ul><p><strong>Research links from the Episode:</strong></p><ul><li><a href="https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.3086">ASCO Conquer Cancer Award - Differential Clinical Trial Outcomes in Japan and the US</a></li><li><a href="https://www.nature.com/articles/s41591-023-02232-8">Nature Medicine Publication - Cancer Cachexia in TRACERx </a></li><li><a href="https://www.prnewswire.com/news-releases/biocortex-unveils-critical-bacteria-interactions-in-adc-cancer-treatment-enabled-by-google-cloud-302270040.html#:~:text=LONDON%2C%20Oct.,by%20leveraging%20Google%20Cloud%20technology.">Google Cloud Press Release - Bacterial Interactions in ADC Cancer Treatment</a></li></ul><p><strong>Rad Chat Links:</strong></p><ul><li><a href="http://www.radchat.co.uk/">Rad Chat Website</a></li><li><a href="https://linktr.ee/radchat">Link Tree</a></li><li><a href="https://www.facebook.com/RadChatPodcast/">Facebook</a></li><li><a href="https://www.instagram.com/rad__chat/">Instagram</a></li><li><a href="https://uk.linkedin.com/company/radtalk">LinkedIn</a></li><li><a href="https://www.tiktok.com/@rad_chat">TikTok</a></li><li><a href="https://bsky.app/profile/radchat.bsky.social">BlueSky</a></li><li><a href="https://www.youtube.com/@radchat2259">YouTube</a></li></ul><p><strong>Credits:</strong> Music and jingle credits: <a href="https://www.linkedin.com/in/ben-imaging/">Dr. Ben Potts</a> and <a href="https://www.linkedin.com/in/adam-cooke-2b9502216/">Adam Cooke</a>.</p>
April 14, 2025
<p><strong>Title:</strong> Living with Metastatic Head and Neck Cancer & Hear the Roar Podcast</p><p><br></p><p><strong>Trigger Warning:</strong> This episode discusses cancer, cancer diagnostics, cancer treatments, metastatic disease, death and dying.</p><p><br></p><p><strong>Episode163: Part of the Living with and Beyond Series(Part53)</strong></p><p><strong>Description:</strong> In this powerful episode, Naman Julka-Anderson and Jo McNamara sit down with Paul Schneider, who shares his experience with cancer and the support he received from charities like Swallows Head and Neck Cancer Charity and how he used his experiences to set up Hear the Roar podcast.</p><p><br></p><p><strong>CPD Reflection Points:</strong></p><ol><li>How can you integrate the insights from the podcast into your practice to improve patient care?</li><li><strong>Understand the psychosocial impact of HNC</strong> on patients, including the emotional and psychological challenges, and how to provide supportive care.</li><li><strong>Evaluate the quality of life(QoL) factors for patients</strong> diagnosed with HNC and strategies to improve QoL during and after treatment.</li></ol><p>Complete this form for your accredited digital badge: <a href="https://bit.ly/3GbtR1X">Digital Badge Form</a>.</p><p><br></p><p><strong>Links from the Episode:</strong></p><ul><li>To see Paul using the PBM equipment and his experience at the time <a href="https://www.youtube.com/watch?v=Qdci65n-Ljc">https://www.youtube.com/watch?v=Qdci65n-Ljc</a></li><li>To download the Hear the Roar podcast interviews, visit <a href="https://heartheroar.buzzsprout.com/">https://heartheroar.buzzsprout.com</a></li><li>Swallows cancer charity. <a href="https://theswallows.org.uk">https://theswallows.org.uk</a></li></ul><p><strong>Research links from the Episode:</strong></p><ul><li>Quality Assessment of PBM Protocols for Oral Complications in Head and Neck Cancer Patients: Part 1. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9300948/">https://pmc.ncbi.nlm.nih.gov/articles/PMC9300948/</a></li><li>Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10048748/">https://pmc.ncbi.nlm.nih.gov/articles/PMC10048748/</a></li></ul><p><strong>Rad Chat Links:</strong></p><ul><li><a href="http://www.radchat.co.uk">Rad Chat Website</a></li><li><a href="https://linktr.ee/radchat">Link Tree</a></li><li><a href="https://www.facebook.com/RadChatPodcast/">Facebook</a></li><li><a href="https://www.instagram.com/rad__chat/">Instagram</a></li><li><a href="https://uk.linkedin.com/company/radtalk">LinkedIn</a></li><li><a href="https://www.tiktok.com/@rad_chat">TikTok</a></li><li><a href="https://bsky.app/profile/radchat.bsky.social">BlueSky</a></li><li><a href="https://www.youtube.com/@radchat2259">YouTube</a></li></ul><p><strong>Credits:</strong> Music and jingle credits: <a href="https://www.linkedin.com/in/ben-imaging/">Dr. Ben Potts</a> and <a href="https://www.linkedin.com/in/adam-cooke-2b9502216/">Adam Cooke</a>.</p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
